Gordon Guyatt's Confession: What the Father of Evidence-Based Medicine Didn't Read (#36)
8 September 2025
With Gordon Guyatt
youth-gender-medicine
Gordon Guyatt built the intellectual architecture of evidence-based medicine, then applied it to pediatric gender interventions and found the evidence wanting. In this episode he also admits signing a statement endorsing those interventions without reading it. The conversation is a case study in how ideological alignment can compromise even the most rigorous scientific minds — and why the framework Guyatt built may ultimately matter more than the positions he now defends.
Gordon Guyatt coined the phrase "evidence-based medicine" in 1991 and spent nearly five decades building the tools physicians use to evaluate research — the hierarchy of evidence, the systematic review, the critical appraisal frameworks taught in medical schools worldwide. His User's Guide to the Medical Literature trained generations of clinicians to ask a deceptively simple question: what does the evidence actually say? That question, applied to pediatric gender medicine, has produced one of the more revealing collisions between scientific integrity and ideological commitment in recent medical history. Guyatt's team conducted systematic reviews of the evidence for youth gender interventions and found it consistently low-quality. This was a methodological finding, not a political one, produced by the very framework he built. Twenty American states subsequently referenced his work in legislation restricting these treatments. His response was to call that use of his findings "egregious" and "unconscionable." The episode invites a pointed question: if the evidence is genuinely low-quality, and policymakers draw conservative conclusions from it, what exactly has been misused? The most striking moment is a straightforward admission. Guyatt signed a public statement endorsing what it described as "medically necessary care for gender diverse youth." When pressed on a specific passage, he acknowledged he had not read it carefully. "That was not my paragraph, and I didn't read carefully enough," he says. Asked to assess his own conduct plainly: "I was a dope. Okay. I'm sometimes a dope." From the architect of critical appraisal of the medical literature, this is a confession that deserves careful attention. Throughout the interview Guyatt describes himself as "a total non-expert in this area." He deflects questions about whether adolescents can meaningfully consent to interventions affecting their fertility. When a pediatric endocrinologist's observation — that discussing fertility preservation with a fourteen-year-old is like talking to a blank wall — is raised, he dismisses it as a "classic anecdote." Yet when asked what supports the existence of a population who genuinely benefit from these interventions, his answer is his personal impression from conversations with such individuals. The asymmetry is notable. The interview also surfaces a historical parallel: the campaign for bone marrow transplants as a treatment for breast cancer. Activists demanded access, the treatment spread widely, and it ultimately proved harmful to many women who received it. Guyatt is familiar with this history. When the parallel to gender medicine is drawn, his response is: "I feel manipulated at the moment." That discomfort is precisely the point. It is the kind of question that evidence-based medicine was designed to force into the open, regardless of how uncomfortable the forcing feels. What the episode ultimately examines is a pattern visible across institutions in this debate: the methodological rigour applied to produce inconvenient findings is not always applied with equal consistency elsewhere. The tools Guyatt built remain sound. Whether those who built them are willing to use those tools in every direction is the larger question this conversation leaves behind.
